| __timestamp | BioMarin Pharmaceutical Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 581800000 |
| Thursday, January 1, 2015 | 634806000 | 671900000 |
| Friday, January 1, 2016 | 661905000 | 876700000 |
| Sunday, January 1, 2017 | 610753000 | 857900000 |
| Monday, January 1, 2018 | 696328000 | 822200000 |
| Tuesday, January 1, 2019 | 715007000 | 778200000 |
| Wednesday, January 1, 2020 | 628116000 | 512600000 |
| Friday, January 1, 2021 | 628793000 | 681000000 |
| Saturday, January 1, 2022 | 649606000 | 662200000 |
| Sunday, January 1, 2023 | 746773000 | 910700000 |
| Monday, January 1, 2024 | 747184000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, innovation is key. BioMarin Pharmaceutical Inc. and Viatris Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Viatris Inc. consistently outpaced BioMarin in R&D spending, with an average annual investment of approximately 735 million dollars, compared to BioMarin's 643 million dollars. Notably, in 2023, Viatris surged ahead, investing 910 million dollars, a 22% increase from its 2014 spending. Meanwhile, BioMarin's R&D expenses peaked in 2023 at 747 million dollars, marking a 62% rise from 2014. This trend highlights Viatris's aggressive push towards innovation, while BioMarin steadily ramps up its efforts. As these companies continue to innovate, their investments in R&D will likely shape the future of pharmaceutical advancements.
R&D Spending Showdown: Sanofi vs Viatris Inc.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs BioMarin Pharmaceutical Inc.
Viatris Inc. or Ascendis Pharma A/S: Who Invests More in Innovation?
Research and Development Investment: Viatris Inc. vs Axsome Therapeutics, Inc.
Research and Development Investment: Viatris Inc. vs CymaBay Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viatris Inc. and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: Viatris Inc. and Soleno Therapeutics, Inc.
Viatris Inc. or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for BioMarin Pharmaceutical Inc. and Viking Therapeutics, Inc.
R&D Spending Showdown: BioMarin Pharmaceutical Inc. vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Celldex Therapeutics, Inc.